CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Chengdu Kanghong Biotechnology Co., Ltd. et al. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding PGR2021-00035 filed by Chengdu Kanghong Biotechnology Co., Ltd. et al. on 2021-01-07. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

PGR2021-00035

Filing Date

2021-01-07

Accorded Filing Date

2021-01-07

Institution Decision Date

—

Last Modified Date

2024-01-11

Proceeding Type

PGR

Termination Date

2021-06-25

Trial Status

Terminated

Parties & Counsel

Patent Information

1 Patent Involved
Respondent Application Number 16159282
Respondent Patent Number 10828345
Legal Expiration Date
2038-10-12 Active (11.9 yrs remaining)
Injunction Viability (35 U.S.C. § 283) Active Threat
Respondent Inventor George D. Yancopoulos
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Terminated

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Termination 2021-06-25
ORDER Granting Unopposed Motions to Dismiss the Petition and Terminate the Proceeding Before Institution 37 C.F.R. §§ 42.5(a), 42.71(a)
37 CFR 42.5

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)
Customer Number 191459
Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
41408 David Marsh +1 202-942-5068
48001 Thomas Triolo +1 914-847-1612
48921 Stephen Gaudet +1 914-847-7376
50370 Neil Miyamoto +1 914-847-7175
50437 Frank Cottingham +1 914-593-1116
58583 Brian Cocca +1 914-847-1421
58714 Ilona Gont +1 914-847-1304
59668 Brandon Schurter +1 914-847-7000

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 17 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 10 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (17): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (10 found):
PTAB: 10
USPTO PTAB Trial 2025-07-14
IPR2025-01269

Fresenius Kabi SwissBiosim, GmbH et al. v. Regeneron Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2023-12-18
IPR2024-00298

Biocon Biologics Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (11253572)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-12-14
IPR2024-00260

Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (11253572)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-11-20
IPR2024-00201

Biocon Biologics Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10888601)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-04-27
IPR2023-00884

Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (11253572)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-03-26
IPR2023-00739

Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10888601)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-02-10
IPR2023-00532

Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10130681)
Status: Final Written Decision
USPTO PTAB Trial 2023-02-10
IPR2023-00533

Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10888601)
Status: Final Written Decision
USPTO PTAB Trial 2023-02-10
IPR2023-00566

Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10888601)
Status: Final Written Decision
USPTO PTAB Trial 2023-01-06
IPR2023-00442

Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10130681)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

92
10

Notice of Refund Paper

2021-07-08 FILING PARTY: BOARD
9

Petitioner's Request for Refund of Post-Institution Fee For Post Grant Review of U.S. Patent No. 10,828,345 Paper

2021-06-28 FILING PARTY: PETITIONER
8

ORDER Granting Unopposed Motions to Dismiss the Petition and Terminate the Proceeding Before Institution 37 C.F.R. §§ 42.5(a), 42.71(a) Paper

2021-06-25 FILING PARTY: BOARD
7

Petitioner's Unopposed Motion to Terminate Proceeding Paper

2021-06-23 FILING PARTY: PETITIONER
2007

'506 File History Exhibits

2021-04-15 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc